Products - Obesity | Topic | NICE

Showing 4 products

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Tirzepatide for managing overweight and obesity (TA1026)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
23 December 2024
Overweight and obesity management
Status:
In development
Programme:
NICE guideline
Expected publication date:
14 January 2025
Semaglutide for preventing major cardiovascular events in people with cardiovascular disease and living with overweight or obesity ID6441
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Orforglipron for managing overweight and obesity [ID6516]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC